FFA
VRTX icon

Farther Finance Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Farther Finance Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.95M Buy
9,471
+4,549
+92% +$2.33M 0.03% 431
2026
Q2 		$2.45M Buy
4,922
+170
+4% +$75.3K 0.02% 654
2026
Q1 		$2.13M Buy
4,752
+331
+7% +$154K 0.02% 620
2025
Q4 		$2M Buy
4,421
+1,028
+30% +$443K 0.02% 577
2025
Q3 		$1.33M Buy
3,393
+487
+17% +$204K 0.02% 598
2025
Q2 		$1.29M Buy
2,906
+35
+1% +$16.1K 0.03% 498
2025
Q1 		$1.39M Buy
2,871
+462
+19% +$215K 0.04% 391
2024
Q4 		$970K Buy
2,409
+107
+5% +$49.6K 0.04% 378
2024
Q3 		$1.07M Sell
2,302
-10
-0.4% -$4.8K 0.04% 332
2024
Q2 		$1.09M Buy
2,312
+1,476
+177% +$641K 0.05% 286
2024
Q1 		$352K Buy
836
+108
+15% +$45.7K 0.02% 484
2023
Q4 		$296K Buy
728
+515
+242% +$190K 0.02% 447
2023
Q3 		$74.1K Buy
213
+68
+47% +$23.8K 0.01% 656
2023
Q2 		$51K Buy
145
+8
+6% +$2.69K 0.01% 667
2023
Q1 		$43.2K Sell
137
-37
-21% -$11.1K 0.01% 641
2022
Q4 		$50.2K Buy
+174
New +$53K 0.02% 484

Other funds holding VRTX

MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GGS
Galvin Gaustad & Stein Scottsdale, Arizona $1.33B AUM 13.15% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
LJHT
Laurie J. Hall Trustee $314M AUM 27.43% 1-Year Est. Return
CFG
Cooper Financial Group Irvine, California $1.26B AUM 21.18% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

Farther Finance Advisors's VRTX Position: Q3 2026 in Review

Farther Finance Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 92% in Q3 2026, buying an estimated $2.33M and bringing the position to 9,471 shares worth $4.95M. The position accounts for 0.03% of the portfolio, ranked #431.

Farther Finance Advisors first reported a position in VRTX in Q4 2022 and has held it in 16 quarters since. 66 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Farther Finance Advisors held 9,471 shares of Vertex Pharmaceuticals worth $4.95M as of Q3 2026.
  • Farther Finance Advisors bought 4,549 Vertex Pharmaceuticals shares in Q3 2026, an estimated $2.33M.
  • Vertex Pharmaceuticals made up 0.03% of Farther Finance Advisors's portfolio in Q3 2026, its #431 holding.
  • Farther Finance Advisors first reported a position in Vertex Pharmaceuticals in Q4 2022 and has held it in 16 quarters since.
  • 66 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.